EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of the Telomere Length in Patients with Spinal Muscular Atrophy

Betül Okur Altındaş, Sedat Öktem, Kürşat Bora Çarman, Mahmut Selman Yıldırım

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262211223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Betül Okur Altındaş und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Necmettin Erbakan University Medical Faculty Hospital, Konya 42090, Türkiye. Hauptthemen laut MEDLINE: Muscular Atrophy, Spinal, Telomere, Telomere Homeostasis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Necmettin Erbakan University, Scientific Research Projects Coordination Unit of Necmettin Erbakan University, Nucleus Genetik Ürünleri A.Ş.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by biallelic SMN1 gene loss, leading to motor neuron degeneration and progressive muscle weakness. The SMN protein is also implicated in telomerase biogenesis, suggesting a possible link between SMA and telomere regulation. This study aimed to investigate relative telomere length in pediatric SMA patients and evaluate, for the first time, the potential effects of gene replacement therapy with onasemnogene abeparvovec. Relative telomere length was measured in peripheral blood lymphocytes using quantitative real-time PCR in 58 patients and 58 age- and sex-matched healthy controls. Of the patients, 19 had received gene replacement therapy. SMA patients without this treatment exhibited significantly shorter telomeres compared with controls (p = 0.029), whereas no significant difference was observed between gene-treated patients and controls (p = 0.108). Direct comparison revealed longer telomeres in treated patients than in untreated ones (p = 0.012). These findings indicate that telomere attrition is present in SMA and may be mitigated by gene replacement. While the exact contribution of telomere biology to SMA pathogenesis remains to be clarified, telomere length may represent a biomarker for disease severity and treatment response, as well as a potential therapeutic target in this disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Atrophy, SpinalTelomereTelomere HomeostasisHumansMaleFemaleChildChild, PreschoolSurvival of Motor Neuron 1 ProteinGenetic TherapyInfantCase-Control StudiesAdolescent

Stichwörter der Autor:innen

SMASMN1spinal muscular atrophytelomere length

Substanzen

Survival of Motor Neuron 1 ProteinSMN1 protein, human

Autor:innen und Institutionen

  • Department of Medical Genetics, Necmettin Erbakan University Medical Faculty Hospital, Konya 42090, Türkiye.
  • Department of Medical Genetics, Dr. Ali Kemal Belviranlı Obstetrics and Gynecology Hospital, Konya 42285, Türkiye.
  • Division of Pediatric Pulmonary Diseases, Department of Pediatrics, Medipol Mega University Hospital, İstanbul 34214, Türkiye.
  • Division of Pediatric Neurology, Department of Pediatrics, Osmangazi University Medical Faculty Hospital, Eskişehir 26040, Türkiye.

Förderung

  • Necmettin Erbakan University
  • Scientific Research Projects Coordination Unit of Necmettin Erbakan University
  • Nucleus Genetik Ürünleri A.Ş

Zitieren

APA

Okur Altındaş, B., Öktem, S., Çarman, K. B., & Yıldırım, M. S. (2025). Evaluation of the Telomere Length in Patients with Spinal Muscular Atrophy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211223

Vancouver

Okur Altındaş B, Öktem S, Çarman KB, Yıldırım MS. Evaluation of the Telomere Length in Patients with Spinal Muscular Atrophy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211223

BibTeX
@article{OkurAltnda2025,
  author = {Okur Altındaş, Betül and Öktem, Sedat and Çarman, Kürşat Bora and Yıldırım, Mahmut Selman},
  title = {Evaluation of the Telomere Length in Patients with Spinal Muscular Atrophy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262211223}
}
Kostenlos starten →